First results of long-term resveratrol study with Veri-te™ published
Many published research and clinical data suggest that resveratrol may be an important ingredient for healthy aging. Several research projects focusing on bone, heart, skin and cognitive health with Veri-te™ Resveratrol are supported and published by our partner Evolva.
Currently the largest and longest running study of its kind is being conducted with Veri-te™ Resveratrol. This two-year placobo- controlled, crossover study called RESHAW (“Supporting healthy aging in women with resveratrol”) is conducted by the University of Newcastle, Australia, with 125 subjects. It investigates the effect of daily resveratrol supplementation on health in postmenopausal women. Viewers will become more explicit about perception and mood, physical function and loss of bone mineral density associated with menopause. The study is expected to be completed by the end of this year.
Evolva is pleased to announce that the initial results of the RESHAW study have already been peer-reviewed and have now been published in Nutrients. The report “Sustainable Cerebrovascular and Cognitive Benefits of Resveratrol in Post-Menopausal Women” is the first in a series of expected publications from the extensive two-year clinical RESHAW study with Veri-te ™ Resveratrol.
The authors summarize this study as follows:
“Our results support the introduction of resveratrol as a cost-effective, effective measure to counteract the age- and menopause-related accelerated cognitive decline in our aging population. Subsequent publications from this study will report on the effects of resveratrol on bone health, physical function, and quality of life, thereby jointly establishing resveratrol as a viable measure to promote healthy aging in women. “
If you are interested in the results of this study and the publications, we will be happy to send them to you.